Correlation Between Intel Corp and CRISPR Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Intel Corp and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intel Corp and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intel Corp and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Intel Corp and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intel Corp with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intel Corp and CRISPR Therapeutics.

Diversification Opportunities for Intel Corp and CRISPR Therapeutics

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Intel and CRISPR is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Intel Corp and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Intel Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intel Corp are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Intel Corp i.e., Intel Corp and CRISPR Therapeutics go up and down completely randomly.

Pair Corralation between Intel Corp and CRISPR Therapeutics

Given the investment horizon of 90 days Intel Corp is expected to under-perform the CRISPR Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Intel Corp is 1.88 times less risky than CRISPR Therapeutics. The stock trades about -0.36 of its potential returns per unit of risk. The CRISPR Therapeutics AG is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  7,401  in CRISPR Therapeutics AG on July 1, 2022 and sell it today you would lose (707.00)  from holding CRISPR Therapeutics AG or give up 9.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Intel Corp  vs.  CRISPR Therapeutics AG

 Performance (%) 
       Timeline  
Intel Corp 
Intel Performance
0 of 100
Over the last 90 days Intel Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in October 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Intel Price Channel

CRISPR Therapeutics 
CRISPR Performance
2 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, CRISPR Therapeutics may actually be approaching a critical reversion point that can send shares even higher in October 2022.

CRISPR Price Channel

Intel Corp and CRISPR Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Intel Corp and CRISPR Therapeutics

The main advantage of trading using opposite Intel Corp and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intel Corp position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.
Intel Corp vs. Amazon Inc
The idea behind Intel Corp and CRISPR Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
CRISPR Therapeutics vs. Molina Healthcare
CRISPR Therapeutics vs. Ltc Properties
CRISPR Therapeutics vs. CVS Corp
CRISPR Therapeutics vs. Elevance Health
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go